CASI Pharmaceuticals
CASI
#10188
Rank
A$24.64 M
Marketcap
A$1.20
Share price
14.86%
Change (1 day)
-70.75%
Change (1 year)

Earnings for CASI Pharmaceuticals (CASI)

Earnings in 2025 (TTM): -A$73.7 Million

According to CASI Pharmaceuticals's latest financial reports the company's current earnings are A$26.84 Million. In 2024 the company made an earning of -A$53.72 Million a decrease over its 2023 earnings that were of -A$37.22 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for CASI Pharmaceuticals from 1996 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -A$73.7 Million37.2%
2024 -A$53.72 Million44.35%
2023 -A$37.22 Million-29.55%
2022 -A$52.82 Million4.43%
2021 -A$50.58 Million-24.56%
2020 -A$67.04 Million4.74%
2019 -A$64.01 Million65.13%
2018 -A$38.77 Million155.07%
2017 -A$15.2 Million13.93%
2016 -A$13.34 Million31.18%
2015 -A$10.17 Million-72.5%
2014 -A$36.98 Million356.62%
2013 -A$8.1 Million-60.55%
2012 -A$20.53 Million218.41%
2011 -A$6.45 Million0.74%
2010 -A$6.4 Million-32.54%
2009 -A$9.49 Million-66.98%
2008 -A$28.73 Million-14.22%
2007 -A$33.49 Million7.04%
2006 -A$31.29 Million27.95%
2005 -A$24.45 Million4.51%
2004 -A$23.4 Million-15.84%
2003 -A$27.8 Million-55.29%
2002 -A$62.18 Million-34.05%
2001 -A$94.28 Million31.73%
2000 -A$71.57 Million31.56%
1999 -A$54.4 Million145.56%
1998 -A$22.16 Million76.4%
1997 -A$12.56 Million36.92%
1996 -A$9.18 Million